methamphetamine has been researched along with naloxone in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (25.93) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 10 (37.04) | 24.3611 |
| 2020's | 3 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sprague, GL; Takemori, AE | 1 |
| Carlson, KR; Eibergen, RD | 1 |
| Kuribara, H; Tadokoro, S | 1 |
| Funahashi, M; Hayashida, H; Hori, O; Kimura, H; Kohda, H | 1 |
| Ebert, DM; Giardina, WJ | 1 |
| Kamata, K; Kameyama, T; Yoshida, S | 1 |
| Kamei, C; Shimomura, K; Ueki, S | 1 |
| Hoaki, Y; Ida, Y; Kohno, Y; Nagasaki, N; Tanaka, M | 1 |
| Balsara, JJ; Burte, NP; Chandorkar, AG; Jadhav, JH; Nandal, NV | 1 |
| Horikoshi, R; Kato, K; Niwa, SI; Shishido, T; Watanabe, Y | 1 |
| Cherng, CF; Kuo, YM; Yu, L | 1 |
| Fujio, M; Kaneko, S; Minami, M; Nakagawa, T; Ozawa, T; Satoh, M; Sekiya, Y; Suzuki, Y | 1 |
| Bevins, RA; Reichel, CM; Wilkinson, JL | 1 |
| Chien, CC; Fan, LW; Ho, IK; Lee, YJ; Tien, LT | 1 |
| Cagniard, B; Murphy, NP | 1 |
| Hall, FS; Kitanaka, J; Kitanaka, N; Nishiyama, N; Takemura, M; Tanaka, K; Uhl, GR | 1 |
| Buxton, JA; DeBeck, K; Goldman-Hasbun, J; Kerr, T; Nosova, E; Wood, E | 1 |
| Leung, LS; Ma, J | 1 |
| Allen, ST; Grieb, SM; O'Rourke, A; Planchet, E; Sherman, SG; White, RH; Yoder, R | 1 |
| Amat, J; Bachtell, RK; Cochran, TA; Fabisiak, TJ; Haas, ME; Hutchinson, MR; Li, H; Maier, SF; Northcutt, AL; Rice, KC; Wang, X; Watkins, LR; Zhang, X | 1 |
| Rodríguez Mega, E | 1 |
| Frank, CJ; Morrison, L | 1 |
| Beardsley, PM; Elder, HJ; Varshneya, NB; Walentiny, DM | 1 |
1 review(s) available for methamphetamine and naloxone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
26 other study(ies) available for methamphetamine and naloxone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effect of methamphetamine on the development of acute morphine tolerance and dependence in mice.
Topics: Analgesics; Animals; Brain; Drug Synergism; Drug Tolerance; Humans; Male; Methamphetamine; Mice; Morphine; Morphine Dependence; Naloxone; Reaction Time; Time Factors | 1978 |
Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Humans; Macaca mulatta; Male; Methadone; Methamphetamine; Naloxone; Phenobarbital; Phentolamine; Physostigmine; Spiperone; Stereotyped Behavior | 1976 |
The ambulation-increasing effect of buprenorphine in mice: comparison with the effect of morphine.
Topics: Animals; Buprenorphine; Caffeine; Cocaine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Locomotion; Male; Methamphetamine; Mice; Morphine; Naloxone; Pilocarpine; Scopolamine | 1991 |
Potentiating effect of morphine upon d-methamphetamine-induced hyperthermia in mice. Effects of naloxone and haloperidol.
Topics: Animals; Body Temperature Regulation; Drug Synergism; Fever; Haloperidol; Male; Methamphetamine; Mice; Morphine; Motor Activity; Naloxone | 1990 |
Positive effects of captopril in the behavioral despair swim test.
Topics: Animals; Arousal; Captopril; Dose-Response Relationship, Drug; Escape Reaction; Imipramine; Methamphetamine; Mianserin; Mice; Mice, Inbred Strains; Motivation; Naloxone; Swimming | 1989 |
Antagonism of footshock stress-induced inhibition of intracranial self-stimulation by naloxone or methamphetamine.
Topics: Animals; Dopamine; Electroshock; Endorphins; Male; Methamphetamine; Naloxone; Rats; Rats, Inbred Strains; Self Stimulation; Stress, Physiological; Synaptic Transmission; Tegmentum Mesencephali | 1986 |
Significance of withdrawal jumping response in predicting physical dependence in mice.
Topics: Amitriptyline; Animals; Atropine; Cannabis; Chlordiazepoxide; Chlorpromazine; Diazepam; Humans; Imipramine; Male; Mephenesin; Methamphetamine; Mice; Morphine Dependence; Naloxone; Pentobarbital; Perphenazine; Phenytoin; Reserpine; Substance Withdrawal Syndrome | 1973 |
Differential modification by opioid agents of acutely enhanced noradrenaline release in discrete brain regions.
Topics: Animals; Brain Chemistry; Glycols; Immobilization; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Opioid; Stress, Physiological | 1983 |
Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.
Topics: Animals; Apomorphine; Catalepsy; Haloperidol; Humans; Male; Methamphetamine; Naloxone; Rats; Stereotyped Behavior | 1984 |
Effects of dopamine, NMDA, opiate, and serotonin-related agents on acute methamphetamine-induced self-injurious behavior in mice.
Topics: 5-Hydroxytryptophan; Animals; Benzazepines; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Motor Activity; N-Methylaspartate; Naloxone; Narcotic Antagonists; Narcotics; Receptors, N-Methyl-D-Aspartate; Self-Injurious Behavior; Serotonin Agents; Sulpiride | 2000 |
Opioid peptides alleviated while naloxone potentiated methamphetamine-induced striatal dopamine depletion in mice.
Topics: Animals; Body Temperature; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Drug Combinations; Drug Synergism; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Naloxone; Narcotic Antagonists; Opioid Peptides | 2001 |
Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats.
Topics: Adenoviridae; Animals; Blotting, Western; Central Nervous System Stimulants; Conditioning, Operant; Excitatory Amino Acid Transporter 2; Gene Transfer Techniques; Male; Methamphetamine; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Rats; Rats, Sprague-Dawley | 2005 |
Methamphetamine functions as a positive and negative drug feature in a Pavlovian appetitive discrimination task.
Topics: Animals; Bupropion; Cocaine; Conditioning, Classical; Discrimination Learning; Male; Methamphetamine; Naloxone; Rats; Rats, Sprague-Dawley | 2007 |
Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice.
Topics: Animals; Blotting, Western; Corpus Striatum; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Interactions; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Naloxone; Narcotic Antagonists; Phosphorylation; Receptors, Opioid, mu; Video Recording | 2012 |
Affective taste responses in the presence of reward- and aversion-conditioned stimuli and their relationship to psychomotor sensitization and place conditioning.
Topics: Affect; Animals; Avoidance Learning; Central Nervous System Stimulants; Conditioning, Operant; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Narcotics; Psychomotor Performance; Quinine; Reinforcement, Psychology; Reward; Sucrose; Taste | 2013 |
Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Male; Methamphetamine; Mice; Mice, Inbred Strains; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Phenazocine; Pyrimidines; Receptors, Opioid, delta; Reflex; Tail; Time Factors | 2012 |
Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; British Columbia; Cohort Studies; Ethnicity; Female; Health Knowledge, Attitudes, Practice; Heroin Dependence; Homeless Youth; Humans; Male; Methamphetamine; Naloxone; Narcotic Antagonists; Prospective Studies; Socioeconomic Factors; Substance-Related Disorders; Young Adult | 2017 |
Generalized seizures evoked by nucleus accumbens stimulation induced an opiate-mediated suppression of psychosis relevant behaviors.
Topics: Animals; Behavior, Animal; Evoked Potentials, Auditory; Hippocampus; Locomotion; Male; Methamphetamine; Motor Activity; Naloxone; Narcotic Antagonists; Nucleus Accumbens; Opiate Alkaloids; Rats, Long-Evans; Reflex, Startle; Seizures | 2019 |
Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Topics: Adult; Amphetamine-Related Disorders; Drug Overdose; Female; Harm Reduction; Health Services Accessibility; Heroin Dependence; HIV Infections; Humans; Ill-Housed Persons; Male; Methamphetamine; Middle Aged; Naloxone; Narcotic Antagonists; Needle Sharing; Needle-Exchange Programs; Opioid-Related Disorders; Public Health; Qualitative Research; Risk-Taking; Rural Health Services; Social Stigma; Substance Abuse, Intravenous; West Virginia | 2019 |
Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
Topics: Animals; Central Nervous System Stimulants; Dopamine; Lymphocyte Antigen 96; Male; Methamphetamine; Microglia; Molecular Dynamics Simulation; Naloxone; Narcotic Antagonists; NF-kappa B; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Ventral Tegmental Area | 2019 |
The psychiatrist at the centre of the opioid crisis.
Topics: Alcoholism; Cocaine-Related Disorders; Dopamine; Drug Overdose; Heroin Dependence; History, 20th Century; History, 21st Century; Humans; Marijuana Abuse; Methadone; Methamphetamine; Naloxone; National Institutes of Health (U.S.); Neurosciences; Opioid-Related Disorders; Positron-Emission Tomography; Prefrontal Cortex; Psychiatry; Reward; Socioeconomic Factors; United States | 2020 |
Harm Reduction for Patients With Substance Use Disorders.
Topics: Adult; Buprenorphine; Contraception; Drug Overdose; Female; Harm Reduction; Heroin; Humans; Male; Methadone; Methamphetamine; Naloxone; Opioid-Related Disorders; Pregnancy; Quality of Life; Referral and Consultation; Substance-Related Disorders | 2022 |
Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner.
Topics: Amphetamine; Analgesics, Opioid; Animals; Central Nervous System Stimulants; Drug Overdose; Fentanyl; Methamphetamine; Mice; Naloxone; Respiration; Respiratory Insufficiency; United States | 2023 |